| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| TEC |
|
transient erythroblastopenia of childhood
|
|
|
0.659 |
0.577 |
| THM |
|
thymoma
|
|
|
0.686 |
0.500 |
| PCAP |
|
predisposing for prostate cancer
|
|
|
0.760 |
0.231 |
| HPCX |
|
hereditary prostate cancer, X-linked
|
|
|
0.805 |
0.154 |
| BRCA1 |
P38398
|
BRCA1 DNA repair associated
|
Enzyme
|
9.2E-29 |
0.367 |
0.923 |
| BRCA2 |
P51587
|
BRCA2 DNA repair associated
|
Nucleic acid binding
|
2.4E-25 |
0.379 |
0.846 |
| CHEK2 |
O96017
|
checkpoint kinase 2
|
Kinase
|
1.2E-24 |
0.460 |
0.808 |
| ELAC2 |
Q9BQ52
|
elaC ribonuclease Z 2
|
|
1.7E-20 |
0.670 |
0.346 |
| MSR1 |
P21757
|
macrophage scavenger receptor 1
|
Enzyme
|
2.2E-20 |
0.553 |
0.654 |
| PALB2 |
Q86YC2
|
partner and localizer of BRCA2
|
|
3.0E-19 |
0.485 |
0.769 |
| AIRE |
O43918
|
autoimmune regulator
|
|
4.0E-12 |
0.516 |
0.808 |
| KRT20 |
P35900
|
keratin 20
|
|
9.1E-11 |
0.388 |
0.846 |
| RNASEL |
Q05823
|
ribonuclease L
|
Kinase
|
2.0E-10 |
0.579 |
0.692 |
| TRIM21 |
P19474
|
tripartite motif containing 21
|
|
3.4E-09 |
0.485 |
0.808 |
| PSAT1 |
Q9Y617
|
phosphoserine aminotransferase 1
|
|
1.1E-08 |
0.478 |
0.846 |
| CD38 |
P28907
|
CD38 molecule
|
Enzyme
|
2.3E-06 |
0.407 |
0.885 |
| LRP1B |
Q9NZR2
|
LDL receptor related protein 1B
|
|
2.5E-06 |
0.626 |
0.615 |
| KLK3 |
P07288
|
kallikrein related peptidase 3
|
Enzyme
|
4.4E-06 |
0.443 |
0.885 |
| MLH1 |
P40692
|
mutL homolog 1
|
Nucleic acid binding
|
3.4E-05 |
0.399 |
0.808 |
| MS4A1 |
P11836
|
membrane spanning 4-domains A1
|
Receptor
|
5.1E-05 |
0.411 |
0.846 |
| PROS1 |
P07225
|
protein S
|
|
4.7E-04 |
0.467 |
0.846 |
| HLA-DRB1 |
P01911
|
major histocompatibility complex, class II, DR beta 1
|
Immune response
|
1.1E-03 |
0.333 |
0.923 |